Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole for Prevention of Post-Cardiac Surgery Acute Kidney Injury
NCT06154226Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- Jan 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of pantoprazole in acute kidney injury (AKI) (2 arms), sponsored by UTHealth Houston. Primary endpoint: Area Under the Curve of Urinary Kidney Injury Biomarker Kidney Injury Molecule-1 Above Baseline at 24 hours. Started Jan 2024; status: completed.
02
Drugs
pantoprazole
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT06154226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06154226.